Conclusion
In this retrospective case series, patients on fertility sparing
treatment for early EC who underwent BS were associated with early
cancer regression within six months. In addition, patients had
significant weight loss and resolution of comorbidities. BS could be a
promising component of fertility sparing treatment for early EC. The
overall and metabolic health benefits from weight loss induced by BS in
this study is consistent with current literature. Larger scale,
prospective case controlled studies with longer follow-up period is
required to confirm the oncological benefit of BS for this purpose. This
study could add to the body of evidence and raise awareness for this
promising treatment strategy, while forming the background data for
future prospective studies.